The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
In biological system, it means to calculate the whole number by marking part of individuals.
The global Biomarkers market was valued at US$ 62940 million in 2023 and is anticipated to reach US$ 165160 million by 2030, witnessing a CAGR of 14.6% during the forecast period 2024-2030.
North America is the largest consumption place, with a consumption market share nearly 32% in 2018. Following North America, Europe is the second largest consumption place with the consumption market share of 22.5%.
This report aims to provide a comprehensive presentation of the global market for Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biomarkers.
Report Scope
The Biomarkers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- Thermo Fisher Scientific
- Merck
- Bio-Rad Laboratories
- QIAGEN
- Roche
- Danaher Corporation
- Siemens Healthcare
- Abbott
- Agilent Technologies
Segment by Type
- Sepsis Biomarkers
- Antibiotic Resistance Biomarkers
- Traumatic Brain Injury (TBI) Testing Biomarkers
- Stroke Testing Biomarkers
- Antibiotic Stewardship Biomarkers
- Other
Segment by Application
- Diagnostics
- Drug Discovery
- Personalized Medicine
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biomarkers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biomarkers Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Sepsis Biomarkers
1.2.3 Antibiotic Resistance Biomarkers
1.2.4 Traumatic Brain Injury (TBI) Testing Biomarkers
1.2.5 Stroke Testing Biomarkers
1.2.6 Antibiotic Stewardship Biomarkers
1.2.7 Other
1.3 Market by Application
1.3.1 Global Biomarkers Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biomarkers Market Perspective (2019-2030)
2.2 Biomarkers Growth Trends by Region
2.2.1 Global Biomarkers Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biomarkers Historic Market Size by Region (2019-2024)
2.2.3 Biomarkers Forecasted Market Size by Region (2025-2030)
2.3 Biomarkers Market Dynamics
2.3.1 Biomarkers Industry Trends
2.3.2 Biomarkers Market Drivers
2.3.3 Biomarkers Market Challenges
2.3.4 Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biomarkers Players by Revenue
3.1.1 Global Top Biomarkers Players by Revenue (2019-2024)
3.1.2 Global Biomarkers Revenue Market Share by Players (2019-2024)
3.2 Global Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biomarkers Revenue
3.4 Global Biomarkers Market Concentration Ratio
3.4.1 Global Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biomarkers Revenue in 2023
3.5 Biomarkers Key Players Head office and Area Served
3.6 Key Players Biomarkers Product Solution and Service
3.7 Date of Enter into Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biomarkers Breakdown Data by Type
4.1 Global Biomarkers Historic Market Size by Type (2019-2024)
4.2 Global Biomarkers Forecasted Market Size by Type (2025-2030)
5 Biomarkers Breakdown Data by Application
5.1 Global Biomarkers Historic Market Size by Application (2019-2024)
5.2 Global Biomarkers Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Biomarkers Market Size (2019-2030)
6.2 North America Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biomarkers Market Size by Country (2019-2024)
6.4 North America Biomarkers Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biomarkers Market Size (2019-2030)
7.2 Europe Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biomarkers Market Size by Country (2019-2024)
7.4 Europe Biomarkers Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biomarkers Market Size (2019-2030)
8.2 Asia-Pacific Biomarkers Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biomarkers Market Size by Region (2019-2024)
8.4 Asia-Pacific Biomarkers Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biomarkers Market Size (2019-2030)
9.2 Latin America Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biomarkers Market Size by Country (2019-2024)
9.4 Latin America Biomarkers Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biomarkers Market Size (2019-2030)
10.2 Middle East & Africa Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biomarkers Market Size by Country (2019-2024)
10.4 Middle East & Africa Biomarkers Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Biomarkers Introduction
11.1.4 Thermo Fisher Scientific Revenue in Biomarkers Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Biomarkers Introduction
11.2.4 Merck Revenue in Biomarkers Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Biomarkers Introduction
11.3.4 Bio-Rad Laboratories Revenue in Biomarkers Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Detail
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Biomarkers Introduction
11.4.4 QIAGEN Revenue in Biomarkers Business (2019-2024)
11.4.5 QIAGEN Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Biomarkers Introduction
11.5.4 Roche Revenue in Biomarkers Business (2019-2024)
11.5.5 Roche Recent Development
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Detail
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Biomarkers Introduction
11.6.4 Danaher Corporation Revenue in Biomarkers Business (2019-2024)
11.6.5 Danaher Corporation Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Detail
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Biomarkers Introduction
11.7.4 Siemens Healthcare Revenue in Biomarkers Business (2019-2024)
11.7.5 Siemens Healthcare Recent Development
11.8 Abbott
11.8.1 Abbott Company Detail
11.8.2 Abbott Business Overview
11.8.3 Abbott Biomarkers Introduction
11.8.4 Abbott Revenue in Biomarkers Business (2019-2024)
11.8.5 Abbott Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Detail
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Biomarkers Introduction
11.9.4 Agilent Technologies Revenue in Biomarkers Business (2019-2024)
11.9.5 Agilent Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
